Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on September 24, 2026.
Evolution of the disclosed total
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 1.50% | +0.49 pt | September 24, 2026 | |
| Two Sigma Investments, LP | 1.28% | new | September 1, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.72% | -0.25 pt | September 11, 2026 | |
| D. E. Shaw & Co., L.P. | 0.65% | new | September 18, 2026 | |
| Lazard Asset Management LLC | 0.59% | +0.01 pt | September 23, 2026 | |
| Walleye Capital LLC | 0.59% | new | September 22, 2026 | |
| Whitebox Advisors LLC | 0.58% | new | June 3, 2026 | |
| Spark Investment Management LLC | 0.52% | new | June 19, 2026 | |
| AQR Capital Management, LLC | 0.51% | new | September 11, 2026 | |
| Jupiter Asset Management Ltd. | 0.51% | new | September 11, 2026 | |
| GSA Capital Partners LLP | 0.50% | new | September 23, 2026 |
In the United States PHGUF (OTC): 12,393,777 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Pharming Group N.V. Titelia
Get the moves on Pharming Group N.V. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 1147 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.86% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at September 24, 2026, https://www.quivad.com/action/pharming-group-n-v?page=14